FDA Alert: Counterfeit Ozempic found in U.S. Supply Chain

The FDA and Novo Nordisk are warning the public about counterfeit Ozempic injections circulating in the U.S. drug supply chain. The falsified products, labeled with lot number PAR0362 and serial numbers beginning with 51746517, were seized by the FDA on April 9, 2025. Their contents and safety are unverified and pose serious health risks.

[...]

Prescription Drug Affordability Board Activity through March 31, 2025

Prescription Drug Affordability Board Activity through March 31, 2025 Activities Summary Colorado: Colorado’s PDAB cancelled its March meetings. Maryland: Maryland’s PDAB met on March 24, 2025 to begin a cost review of Farxiga and review feedback about updates to PDAB regulations. Oregon: Board members met on March 19, 2025, where they elected a subset of…

[...]

Handout: What is an Alternative Funding Program?

Some employers are hiring consultants, sometimes called “Alternative Funding Program (AFP) vendors” or
“importation program vendors,” to supply employees and their families with illegally imported and unsafe
medicines.

[...]